Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
Recalled 2022-06-30. Choking hazard. Here is what the CPSC published, and what you are owed.
About 9,000Units
2022-06-30Recall date
None reportedInjuries
The text below is quoted from the CPSC notice word for word.
- What was recalled
- The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.
- The hazard
- The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.
- Injuries
- None reported
- The remedy
- Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.
The details
What a recall entitles you to
A refund, a repair or a replacement. The notice says which. It costs you
nothing and there is usually no receipt requirement.
Stop using the product first. Recalls do not expire. An old one still counts.
The full CPSC notice, including photographs, is at cpsc.gov.
Source: CPSC SaferProducts recall feed, retrieved 2026-08-06. Newest recall on file 2026-07-30.
More choking recalls · Recalls in 2022 · All product recalls